A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
for
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Location: DuBois PA, Columbus OH, Boerne TX
Sponsor: UCB Biopharma SRL
Sex: All
Age: 40 - 70+
Code: NCT07725939
Phase2, Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: New York NY, Philadelphia PA, Falls Church VA,
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT07561034
Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
for
Pulmonary Hypertension,
Location: Mechanicsburg PA, Cleveland OH, Detroit MI, Houma LA,